In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Value Lab: Moving Value-Based Health Care From Theory To Practice

Executive Summary

Although stakeholders are interested in value-based models that link a drug’s performance to emerging evidence of improved patient outcomes, such agreements are difficult to implement and too limited in scope to drive a shift to value-based reimbursement. The authors suggest a new, structured approach to bring these contracts into the mainstream, thus transforming product reimbursement and fueling the shift from volume to value.

Advertisement

Related Content

Brilinta/Bydureon’s Measurable Outcomes Are Smooth Fit For Contracts
Price Rebates Will Continue As ‘Fact Of Life’ In Drug Contracting
US Outcomes-Based Contracts: Big Uptick In Interest, But Not Execution
Smart Segmentation: Success In The Payer-Dominated Pharma Marketplace
Lilly's Performance Contract For Trulicity Hinges On Head-To-Head Superiority
A Road Map To Strategic Drug Pricing
Scoring Value: New Tools Challenge Pharma's US Pricing Bonanza

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV005130

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel